Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD-057 vs Humira PK and Safety Study in Healthy Volunteers
NCT02395055Phase 1Completed
- Sponsor
- BIOCAD
- Start
- Jun 2015
- Primary completion
- Oct 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BCD-057 in rheumatoid arthritis (RA) (2 arms), sponsored by BIOCAD. Primary endpoints: Maximum Concentration and Area Under the Plasma Concentration-time Curve From Zero to Infinity. Started Jun 2015; status: completed.
02
Drugs
BCD-057
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02395055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395055.